Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study

Jay Shavadia, Robert Welsh, Anthony Gershlick, Yinggan Zheng, Kurt Huber, Sigrun Halvorsen, Phillipe G Steg, Frans Van de Werf, Paul W Armstrong, Jay Shavadia, Robert Welsh, Anthony Gershlick, Yinggan Zheng, Kurt Huber, Sigrun Halvorsen, Phillipe G Steg, Frans Van de Werf, Paul W Armstrong

Abstract

Background: The effectiveness of radial access (RA) in ST-elevation myocardial infarction (STEMI) has been predominantly established in primary percutaneous coronary intervention (pPCI) with limited exploration of this issue in the early postfibrinolytic patient. The purpose of this study was to compare the effectiveness and safety of RA versus femoral (FA) access in STEMI undergoing either a pharmacoinvasive (PI) strategy or pPCI.

Methods and results: Within STrategic Reperfusion Early After Myocardial Infarction (STREAM), we evaluated the relationship between arterial access site and primary outcome (30-day composite of death, shock, congestive heart failure, or reinfarction) and major bleeding according to the treatment strategy received. A total of 1820 STEMI patients were included: 895 PI (49.2%; rescue PCI [n=379; 42.3%], scheduled PCI [n=516; 57.7%]) and 925 pPCI (50.8%). Irrespective of treatment strategy, there was comparable utilization of either access site (FA: PI 53.4% and pPCI 57.6%). FA STEMI patients were younger, had lower presenting systolic blood pressure, lesser Thrombolysis In Myocardial Infarction risk, and more ∑ST-elevation at baseline. The primary composite endpoint occurred in 8.9% RA versus 15.7% FA patients (P<0.001). On multivariable analysis, this benefit on the primary composite outcome favoring RA persisted (adjusted odds ratio [OR], 0.59; 95% CI, 0.44-0.78; P<0.001) and was evident in both pPCI (adjusted OR, 0.63; 95% CI, 0.43-0.92) and PI cohorts (adjusted OR, 0.57 95% CI, 0.37-0.86; P interaction=0.730). There was no difference in nonintracranial major bleeding with either access group (RA vs FA, 5.2% vs 6.0%; P=0.489).

Conclusions: Regardless of the application of a PI or pPCI strategy, RA was associated with improved clinical outcomes, supporting current STEMI evidence in favor of RA in PCI.

Clinical trial registration: URL: https://www.clinicaltrials.gov/. Unique identifier: NCT00623623.

Keywords: ST‐segment elevation myocardial infarction; arterial access; pharmacoinvasive strategy; primary percutaneous coronary intervention.

© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

Figures

Figure 1
Figure 1
Study patients’ flow chart. FA indicates femoral; PI, pharmacoinvasive; pPCI, primary percutaneous coronary intervention; RA, radial.
Figure 2
Figure 2
Upper panel: association between access site and primary endpoints irrespective of treatment strategy. Lower panel: association between access site and primary endpoints according to treatment strategy. Odds ratio (OR) was propensity score adjusted as an inverse probability weight. FA indicates femoral; PI, pharmacoinvasive; pPCI, primary percutaneous coronary intervention; RA, radial.

References

    1. Karrowni W, Vyas A, Giacomino B, Schweizer M, Blevins A, Girotra S, Horwitz P. Radial versus femoral access for primary percutaneous interventions in ST‐segment elevation myocardial infarction patients: a meta‐analysis of randomized controlled trials. JACC Cardiovasc Interv. 2013;8:14–23.
    1. Romagnoli E, Biondi‐Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, Summaria F, Patrizi R, Borghi A, Di Russo C, Moretti C, Agostoni P, Loschiavo P, Lioy E, Sheiban I, Sangiorgi G. Radial versus femoral randomized investigation in ST‐segment elevation acute coronary syndrome: the RIFLE‐STEACS (Radial Versus Femoral Randomized Investigation in ST‐Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60:2481–2489.
    1. Bernat I, Horak D, Stasek J, Mates M, Pesek J, Ostadal P, Hrabos V, Dusek J, Koza J, Sembera Z, Brtko M, Aschermann O, Smid M, Polansky P, Mawiri AA, Vojacek J, Bis J, Costerousse O, Bertrand O, Rokyta R. ST‐segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI‐RADIAL trial. J Am Coll Cardiol. 2014;63:964–972.
    1. Ratib K, Mamas M, Anderson S, Bhatia G, Routledge H, Belder MD, Ludman P, Fraser D, Nolan J. Access site practice and procedural outcomes in relation to clinical presentation in 439,947 patients undergoing percutaneous coronary intervention in the United Kingdom. JACC Cardiovasc Interv. 2015;8:20–29.
    1. Hamon M, Coste P, Van't Hof A, Ten Berg J, Clemmensen P, Tabone X, Benamer H, Kristensen SD, Cavallini C, Marzocchi A, Hamm C, Kanic V, Bernstein D, Anthopoulos P, Deliargyris EN, Steg PG. Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial. Circ Cardiovasc Interv. 2015;8:e002049.
    1. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta‐analysis of randomized trials. Am Heart J. 2009;157:132–140.
    1. Mehta SR, Jolly SS, Cairns J, Niemela K, Rao SV, Cheema AN, Steg PG, Cantor WJ, Dzavik V, Budaj A, Rokoss M, Valentin V, Gao P, Yusuf S; Investigators R . Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST‐segment elevation. J Am Coll Cardiol. 2012;60:2490–2499.
    1. Valgimigli M, Gagnor A, Calabro P, Frigoli E, Leonardi S, Zaro T, Rubartelli P, Briguori C, Ando G, Repetto A, Limbruno U, Cortese B, Sganzerla P, Lupi A, Galli M, Colangelo S, Ierna S, Ausiello A, Presbitero P, Sardella G, Varbella F, Esposito G, Santarelli A, Tresoldi S, Nazzaro M, Zingarelli A, de Cesare N, Rigattieri S, Tosi P, Palmieri C, Brugaletta S, Rao SV, Heg D, Rothenbuhler M, Vranckx P, Juni P; Investigators M . Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385:2465–2476.
    1. Hamon M, Pristipino C, Di Mario C, Nolan J, Ludwig J, Tubaro M, Sabate M, Mauri‐Ferre J, Huber K, Niemela K, Haude M, Wijns W, Dudek D, Fajadet J, Kiemeneij F; European Association of Percutaneous Cardiovascular I, Working Group on Acute Cardiac Care of the European Society of C, Working Group on Thrombosis on the European Society of C . Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology. EuroIntervention. 2013;8:1242–1251.
    1. Rao SV, Tremmel JA, Gilchrist IC, Shah PB, Gulati R, Shroff AR, Crisco V, Woody W, Zoghbi G, Duffy PL, Sanghvi K, Krucoff MW, Pyne CT, Skelding KA, Patel T, Pancholy SB; Society for Cardiovascular A, Intervention's Transradial Working G . Best practices for transradial angiography and intervention: a consensus statement from the society for cardiovascular angiography and intervention's transradial working group. Catheter Cardiovasc Interv. 2014;83:228–236.
    1. Task Force on the Management of STseamiotESoC , Steg PG, James SK, Atar D, Badano LP, Blomstrom‐Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez‐Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van ‘t Hof A, Widimsky P, Zahger D. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST‐segment elevation. Eur Heart J. 2012;33:2569–2619.
    1. Wang Y, Fu X, Wang X, Gu X, Zhao Y, Hao G, Jiang Y, Li S, Wu W, Fan W. Randomized comparison of radial versus femoral approach for patients with STEMI undergoing early PCI following intravenous thrombolysis. J Invasive Cardiol. 2012;24:412–416.
    1. Johnman C, Pell JP, Mackay DF, Behan M, Slack R, Oldroyd KG, Berry C. Clinical outcomes following radial versus femoral artery access in primary or rescue percutaneous coronary intervention in Scotland: retrospective cohort study of 4534 patients. Heart. 2012;98:552–557.
    1. Cruden NL, Teh CH, Starkey IR, Newby DE. Reduced vascular complications and length of stay with transradial rescue angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv. 2007;70:670–675.
    1. Welsh RC, Van de Werf F, Westerhout CM, Goldstein P, Gershlick AH, Wilcox RG, Danays T, Bluhmki E, Lopes RD, Steg PG, Armstrong PW. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study). Am J Cardiol. 2014;114:811–819.
    1. Armstrong P, Gershlick A, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Ortiz FR, Ostojic M, Welsh R, Carvalho A, Nanas J, Arntz H, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F; STREAM Investigative Team . Fibrinolysis or primary PCI in ST‐segment elevation myocardial infarction. N Engl J Med. 2013;368:1379–1387.
    1. Armstrong P, Gershlick A, Goldstein P, Wilcox R, Danays T, Bluhmki E, Van de Werf F; STREAM Steering Committee . The strategic reperfusion early after myocardial infarction (STREAM) study. Am Heart J. 2010;160:30–35.
    1. Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van ‘t Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW. ST‐segment recovery and outcome after primary percutaneous coronary intervention for ST‐elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX‐AMI) trial. Circulation. 2008;118:1335–1346.
    1. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med. 1985;312:932–936.
    1. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med. 1993;329:673–682.
    1. Kurth T, Walker A, Glynn R, Chan K, Gaziano J, Berger K, Robins J. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity‐based weighting under conditions of nonuniform effect. Am J Epidemiol. 2005;163:262–270.
    1. Bertrand O, Patel T. Radial approach for primary percutaneous coronary intervention: ready for prime time? J Am Coll Cardiol. 2012;60:2500–2503.
    1. Kadakia MB, Rao SV, McCoy L, Choudhuri PS, Sherwood MW, Lilly S, Kobayashi T, Kolansky DM, Wilensky RL, Yeh RW, Giri J. Transradial versus transfemoral access in patients undergoing rescue percutaneous coronary intervention after fibrinolytic therapy. JACC Cardiovasc Interv. 2015;8:1868–1876.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다